Drug Shortage Report for ASMANEX TWISTHALER
Report ID | 106456 |
Drug Identification Number | 02243596 |
Brand name | ASMANEX TWISTHALER |
Common or Proper name | mometasone furoate dry powder inhaler |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MOMETASONE FUROATE |
Strength(s) | 400MCG |
Dosage form(s) | POWDER |
Route of administration | INHALATION |
Packaging size | 60dose |
ATC code | R03BA |
ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-05-29 |
Actual start date | 2020-05-25 |
Estimated end date | 2021-07-16 |
Actual end date | 2021-07-16 |
Shortage status | Resolved |
Updated date | 2021-07-17 |
Company comments | Back orders were partially released on Jul 23th 2020, Sep 11th 2020, Oct 28th 2020 and Feb 15th 2021. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.